US Stock MarketDetailed Quotes

Intellia Therapeutics (NTLA)

Watchlist
  • 12.690
  • -0.980-7.17%
Close May 18 16:00 ET
  • 12.740
  • +0.050+0.39%
Post 20:01 ET
1.77BMarket Cap-3.61P/E (TTM)

Intellia Therapeutics (NTLA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
21.21%-117.35M
-13.14%-394.74M
18.67%-69.29M
9.36%-76.9M
-71.21%-99.62M
-23.43%-148.93M
11.47%-348.88M
8.45%-85.2M
16.32%-84.84M
35.58%-58.19M
Net income from continuing operations
15.83%-96.23M
20.49%-412.69M
25.69%-95.79M
25.34%-101.32M
31.11%-101.26M
-6.42%-114.33M
-7.86%-519.02M
2.47%-128.9M
-11.04%-135.71M
-18.83%-146.98M
Operating gains losses
----
793.42%527K
----
----
----
----
-100.48%-76K
--0
----
----
Depreciation and amortization
-11.85%2.2M
54.82%15.92M
134.41%6.02M
89.26%4.94M
-4.81%2.47M
-0.56%2.5M
14.58%10.29M
4.06%2.57M
13.89%2.61M
19.77%2.6M
Other non cash items
----
----
----
----
----
----
-411.82%-20.97M
--0
--0
--0
Change In working capital
36.78%-37.17M
-720.91%-73.75M
-75.78%494K
-55.65%4.41M
-167.08%-19.87M
-97.75%-58.78M
122.65%11.88M
-34.41%2.04M
172.61%9.94M
695.46%29.62M
-Change in receivables
116.96%337K
-103.40%-951K
369.44%1.58M
-91.28%303K
-103.52%-849K
-6,951.72%-1.99M
185.47%27.94M
101.12%337K
342.26%3.47M
16,059.60%24.1M
-Change in prepaid assets
-6,050.46%-12.97M
-608.33%-26.35M
-1,706.28%-8.69M
-311.68%-23.04M
105.62%5.16M
102.49%218K
119.08%5.18M
103.52%541K
289.98%10.88M
298.50%2.51M
-Change in payables and accrued expense
17.91%-13.37M
119.98%716K
196.64%15.99M
311.39%2.74M
-124.04%-1.73M
3.27%-16.28M
-141.93%-3.58M
-58.46%5.39M
-63.17%667K
-27.93%7.2M
-Change in other current assets
226.17%8.34M
60.38%35.9M
74.52%10.23M
570.00%33.93M
-128.65%-1.66M
-216.44%-6.61M
22.28%22.38M
17.45%5.86M
14.00%5.06M
25.54%5.78M
-Change in other current liabilities
55.77%-12.84M
-205.81%-54.95M
-9.21%-4.64M
1.01%-4.63M
-264.67%-16.66M
-547.51%-29.03M
-7.81%-17.97M
4.71%-4.25M
-16.92%-4.67M
-20.33%-4.57M
-Change in other working capital
-30.72%-6.66M
-27.34%-28.11M
-139.18%-13.98M
10.36%-4.91M
23.38%-4.13M
5.09%-5.1M
-694.67%-22.08M
-116.73%-5.85M
37.70%-5.47M
62.45%-5.39M
Cash from discontinued investing activities
Operating cash flow
21.21%-117.35M
-13.14%-394.74M
18.67%-69.29M
9.36%-76.9M
-71.21%-99.62M
-23.43%-148.93M
11.47%-348.88M
8.45%-85.2M
16.32%-84.84M
35.58%-58.19M
Investing cash flow
Cash flow from continuing investing activities
-29.70%66.31M
81.60%228.03M
-81.83%27.53M
90.39%-741K
541.96%106.91M
1,498.51%94.33M
500.57%125.57M
229.93%151.57M
-109.70%-7.71M
29.96%-24.19M
Net PPE purchase and sale
89.25%-79K
80.46%-1.13M
87.16%-126K
97.73%-29K
76.38%-239K
70.67%-735K
58.68%-5.78M
35.46%-981K
70.48%-1.28M
76.47%-1.01M
Net intangibles purchase and sale
----
----
----
----
----
----
--0
----
----
----
Net investment purchase and sale
-30.16%66.39M
74.47%229.16M
-81.87%27.66M
88.93%-712K
562.29%107.15M
1,030.76%95.06M
856.51%131.35M
221.43%152.55M
-107.67%-6.43M
23.35%-23.18M
Cash from discontinued investing activities
Investing cash flow
-29.70%66.31M
81.60%228.03M
-81.83%27.53M
90.39%-741K
541.96%106.91M
1,498.51%94.33M
500.57%125.57M
229.93%151.57M
-109.70%-7.71M
29.96%-24.19M
Financing cash flow
Cash flow from continuing financing activities
33.57M
-29.21%131.49M
-14.67%1.98M
39.74%114.86M
-64.48%14.65M
0
42.53%185.75M
-97.82%2.32M
330.28%82.19M
1,539.35%41.25M
Net common stock issuance
--33.57M
-27.54%128.18M
--0
42.56%114.76M
-65.06%13.42M
--0
47.67%176.9M
-100.03%-30K
446.93%80.5M
--38.4M
Proceeds from stock option exercised by employees
----
-62.58%3.31M
-15.76%1.98M
-94.28%97K
-56.57%1.24M
--0
-15.96%8.85M
-18.31%2.35M
-61.34%1.7M
13.20%2.85M
Cash from discontinued financing activities
Financing cash flow
--33.57M
-29.21%131.49M
-14.67%1.98M
39.74%114.86M
-64.48%14.65M
--0
42.53%185.75M
-97.82%2.32M
330.28%82.19M
1,539.35%41.25M
Net cash flow
Beginning cash position
-17.37%167.57M
-15.63%202.79M
54.62%207.34M
17.77%170.13M
-20.15%148.19M
-15.63%202.79M
-55.11%240.35M
-25.91%134.1M
-21.39%144.45M
-39.37%185.58M
Current changes in cash
68.01%-17.47M
6.25%-35.22M
-157.91%-39.77M
459.45%37.22M
153.34%21.94M
0.30%-54.6M
87.27%-37.57M
15.70%68.69M
-272.58%-10.35M
66.38%-41.13M
End cash Position
1.29%150.1M
-17.37%167.57M
-17.37%167.57M
54.62%207.34M
17.77%170.13M
-20.15%148.19M
-15.63%202.79M
-15.63%202.79M
-25.91%134.1M
-21.39%144.45M
Free cash flow
21.54%-117.43M
-11.62%-395.87M
19.45%-69.41M
10.67%-76.93M
-68.69%-99.86M
-21.51%-149.67M
13.09%-354.66M
8.88%-86.18M
18.54%-86.12M
37.44%-59.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 21.21%-117.35M-13.14%-394.74M18.67%-69.29M9.36%-76.9M-71.21%-99.62M-23.43%-148.93M11.47%-348.88M8.45%-85.2M16.32%-84.84M35.58%-58.19M
Net income from continuing operations 15.83%-96.23M20.49%-412.69M25.69%-95.79M25.34%-101.32M31.11%-101.26M-6.42%-114.33M-7.86%-519.02M2.47%-128.9M-11.04%-135.71M-18.83%-146.98M
Operating gains losses ----793.42%527K-----------------100.48%-76K--0--------
Depreciation and amortization -11.85%2.2M54.82%15.92M134.41%6.02M89.26%4.94M-4.81%2.47M-0.56%2.5M14.58%10.29M4.06%2.57M13.89%2.61M19.77%2.6M
Other non cash items -------------------------411.82%-20.97M--0--0--0
Change In working capital 36.78%-37.17M-720.91%-73.75M-75.78%494K-55.65%4.41M-167.08%-19.87M-97.75%-58.78M122.65%11.88M-34.41%2.04M172.61%9.94M695.46%29.62M
-Change in receivables 116.96%337K-103.40%-951K369.44%1.58M-91.28%303K-103.52%-849K-6,951.72%-1.99M185.47%27.94M101.12%337K342.26%3.47M16,059.60%24.1M
-Change in prepaid assets -6,050.46%-12.97M-608.33%-26.35M-1,706.28%-8.69M-311.68%-23.04M105.62%5.16M102.49%218K119.08%5.18M103.52%541K289.98%10.88M298.50%2.51M
-Change in payables and accrued expense 17.91%-13.37M119.98%716K196.64%15.99M311.39%2.74M-124.04%-1.73M3.27%-16.28M-141.93%-3.58M-58.46%5.39M-63.17%667K-27.93%7.2M
-Change in other current assets 226.17%8.34M60.38%35.9M74.52%10.23M570.00%33.93M-128.65%-1.66M-216.44%-6.61M22.28%22.38M17.45%5.86M14.00%5.06M25.54%5.78M
-Change in other current liabilities 55.77%-12.84M-205.81%-54.95M-9.21%-4.64M1.01%-4.63M-264.67%-16.66M-547.51%-29.03M-7.81%-17.97M4.71%-4.25M-16.92%-4.67M-20.33%-4.57M
-Change in other working capital -30.72%-6.66M-27.34%-28.11M-139.18%-13.98M10.36%-4.91M23.38%-4.13M5.09%-5.1M-694.67%-22.08M-116.73%-5.85M37.70%-5.47M62.45%-5.39M
Cash from discontinued investing activities
Operating cash flow 21.21%-117.35M-13.14%-394.74M18.67%-69.29M9.36%-76.9M-71.21%-99.62M-23.43%-148.93M11.47%-348.88M8.45%-85.2M16.32%-84.84M35.58%-58.19M
Investing cash flow
Cash flow from continuing investing activities -29.70%66.31M81.60%228.03M-81.83%27.53M90.39%-741K541.96%106.91M1,498.51%94.33M500.57%125.57M229.93%151.57M-109.70%-7.71M29.96%-24.19M
Net PPE purchase and sale 89.25%-79K80.46%-1.13M87.16%-126K97.73%-29K76.38%-239K70.67%-735K58.68%-5.78M35.46%-981K70.48%-1.28M76.47%-1.01M
Net intangibles purchase and sale --------------------------0------------
Net investment purchase and sale -30.16%66.39M74.47%229.16M-81.87%27.66M88.93%-712K562.29%107.15M1,030.76%95.06M856.51%131.35M221.43%152.55M-107.67%-6.43M23.35%-23.18M
Cash from discontinued investing activities
Investing cash flow -29.70%66.31M81.60%228.03M-81.83%27.53M90.39%-741K541.96%106.91M1,498.51%94.33M500.57%125.57M229.93%151.57M-109.70%-7.71M29.96%-24.19M
Financing cash flow
Cash flow from continuing financing activities 33.57M-29.21%131.49M-14.67%1.98M39.74%114.86M-64.48%14.65M042.53%185.75M-97.82%2.32M330.28%82.19M1,539.35%41.25M
Net common stock issuance --33.57M-27.54%128.18M--042.56%114.76M-65.06%13.42M--047.67%176.9M-100.03%-30K446.93%80.5M--38.4M
Proceeds from stock option exercised by employees -----62.58%3.31M-15.76%1.98M-94.28%97K-56.57%1.24M--0-15.96%8.85M-18.31%2.35M-61.34%1.7M13.20%2.85M
Cash from discontinued financing activities
Financing cash flow --33.57M-29.21%131.49M-14.67%1.98M39.74%114.86M-64.48%14.65M--042.53%185.75M-97.82%2.32M330.28%82.19M1,539.35%41.25M
Net cash flow
Beginning cash position -17.37%167.57M-15.63%202.79M54.62%207.34M17.77%170.13M-20.15%148.19M-15.63%202.79M-55.11%240.35M-25.91%134.1M-21.39%144.45M-39.37%185.58M
Current changes in cash 68.01%-17.47M6.25%-35.22M-157.91%-39.77M459.45%37.22M153.34%21.94M0.30%-54.6M87.27%-37.57M15.70%68.69M-272.58%-10.35M66.38%-41.13M
End cash Position 1.29%150.1M-17.37%167.57M-17.37%167.57M54.62%207.34M17.77%170.13M-20.15%148.19M-15.63%202.79M-15.63%202.79M-25.91%134.1M-21.39%144.45M
Free cash flow 21.54%-117.43M-11.62%-395.87M19.45%-69.41M10.67%-76.93M-68.69%-99.86M-21.51%-149.67M13.09%-354.66M8.88%-86.18M18.54%-86.12M37.44%-59.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 18 Eastern Time, Trump temporarily halted the planned 'major' military strike on Iran, citing that Gulf allies requested room for neg Show More